Etrasimod (APD334), an Oral, Next‐Generation Sphingosine‐1‐Phosphate Receptor Modulator Inhibits the Development of Colitis in Lymphoid‐Null Mice Injected with Colitogenic CD4+ T Cells
John Adams, Hussien Al‐Shamma(Beacon Clinical Research), Hongmei He(Arena Pharmaceuticals (United States)), Michelle Solomon(Beacon Clinical Research), Dominic P. Behan, Karin Lehmann‐Bruinsma(Beacon Clinical Research), Christopher J. Carroll(St George's, University of London)
Cited by 2
Related Papers
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386
A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release
|Endocrinology|2008|382
Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury
|Journal of Molecular and Cellular Cardiology|2006|312
Mitochondrial myopathy induces a starvation-like response
|Human Molecular Genetics|2010|306